Despite muted response from retail investors, Mankind Pharma IPO subscribed 15 times The portion reserved for QIBs was subscribed over 49 times, while quota for NIIs and retail investors were booked 3.8% times and 0.9 times, respectively. By Chitranjan Kumar
